Nuvation Bio Inc. — Form D

Nuvation Bio Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-20. The offering totals $275.3M, of which $275.3M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2020-10-20
• Form: D
• Accession: 0001739074-20-000013
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $275.3M
• Amount sold: $275.3M
• Investors: 57
• Date of first sale: 2019-06-17
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-378335

Issuer

• Name: Nuvation Bio Inc.
• CIK: 0001829093
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 1500 BROADWAY, NEW YORK, NY, 10036
• Phone: 650-245-3818

Officers, directors & promoters (9)

More

• CIK 1829093 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search